Year: 2024
Type: dissertation
Abstract: Cardiovascular disease (CVD) is a name for a group of diseases that affect the heart or blood vessels. There is a worldwide concern about CVD due to the fact that the incidence of CVD is increasing and this group of diseases is the leading cause of mortality in the world. Advanced glycation end products are products of a non-enzymatic process involving a reaction between reducing sugar, a sugar with the ability to reduce another compound, with proteins, nucleic acids, or lipids. When those products attach to their receptor, they induce inflammation and oxidative stress and promote the generation of reactive oxygen species. This literature review aims to check the link between GGP and cardiovascular diseases and to review the pathological effects that GGP have on the cardiovascular system.
Author: Shehter, Michael
Institution: Lithuanian University of Health Sciences
Language: English
Subfield: Clinical Biochemistry
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7132162774
